Want to see IN:JAGSNPHARM full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is 3.00, suggesting Jagsonpal Pharmaceuticals Ltd. is a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 228.42, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 221.53, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points
Classic
218.98
223.27
229.43
233.72
239.88
244.17
250.33
Fibonacci
223.27
227.26
229.72
233.72
237.71
240.17
244.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages
MA5
234.00Buy
233.44Buy
MA10
228.30Buy
230.76Buy
MA20
227.68Buy
228.42Buy
MA50
220.57Buy
221.53Buy
MA100
208.08Buy
213.46Buy
MA200
201.34Buy
211.21Buy
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 230.76, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 213.46, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 220.57, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 208.08, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 201.34, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators
RSI (14)
59.64
Neutral
STOCH (9,6)
39.84
Neutral
STOCHRSI (14)
39.84
Neutral
MACD (12,26)
3.00
Sell
ADX (14)
31.24
Neutral
Williams %R
-55.19
Buy
CCI (14)
97.31
Neutral
ATR (14)
9.99
-
Ultimate Oscillator
45.05
Neutral
ROC
5.53
Buy
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 59.64, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 31.24, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is 97.31, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is 5.53, creating a Buy signal.
FAQ
Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Strong Buy.
What is JAGSNPHARM’s RSI (14)?
JAGSNPHARM’s RSI (14) is 59.64, which suggests JAGSNPHARM is a Neutral.
What is JAGSNPHARM’s MACD?
JAGSNPHARM’s MACD is 3.00, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 5-day moving average?
JAGSNPHARM’s 5-day moving average is 234.00, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 20-day moving average?
JAGSNPHARM 20-day moving average is 227.68, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 50-day moving average?
JAGSNPHARM’s 50-day moving average is 220.57, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 200-day moving average?
JAGSNPHARM’s 200-day moving average is 201.34, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s Williams % R (14)?
JAGSNPHARM’s Williams % R (14) is -55.19, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s CCI (14)?
JAGSNPHARM’s CCI (14) is 97.31, which suggests JAGSNPHARM is a Neutral.
What is the share price of Jagsonpal Pharmaceuticals Ltd.?